Clinical trials: Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy
Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy
SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma
This study was designed to compare the efficacy and safety of SHR2554 with Chidamide in patients with relapsed/refractory PTCL.
- Trial name
- NCT06122389
- Testing
- SHR2554; Chidamide analog tablets, SHR2554 analog tablets; Chidamide
- Where
- China
- Volunteers
- 130 people
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.